|
序 列 ： |
The synthetic peptide used to raise the antibody Cat. No. 250880 is selected from a sequence within the N-term region of human TGFR2. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended. |
| 分 子 式 ： |
C66H103N17O20 |
|
分 子 量 ： |
1454.6 g/mol |
|
純 度 ： |
Purity > 80% by HPLC |
|
形 態 ： |
Each vial contains 0.1 ml peptide in deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect. |
|
溶 解： |
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile. |
|
保存條件 ： |
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C. |
| 別 名 ： |
TGF-beta receptor type-2; Transforming growth factor-beta receptor type II; TGF-beta receptor type II; TGF-beta type II receptor; TbetaR-II; TGFR-2; TGFBR2 |
| 產品鏈接 ： |
http://www.ABBIOTEC.com/peptides/tgf-beta-receptor-type-ii-peptide |
|
產品說明 ： |
|
| 產品描述 ： |
TGF-beta receptor type II (TGFR2) forms a heteromeric complex with TGFR1 after binding TGF-beta at the cell surface and activates TGFR2 by phosphorylation, subsequently binding and activation of the SMAD transcriptional regulators. Defects in TGFR2 are a cause of hereditary non-polyposis colorectal cancer type 6 (HNPCC6), esophageal cancer, and Loeys-Dietz syndromes (aortic aneurism syndrome). |
